AHF Demands Gilead Drop Exclusive Orphan Drug Claim on COVID-19 Treatment | Financial Buzz

AHF Demands Gilead Drop Exclusive Orphan Drug Claim on COVID-19 Treatment

Gilead—long a calculating and cold-hearted profiteer off the AIDS epidemic—is socializing the risk while privatizing the profits with its reprehensible conduct—using taxpayer financed research to gain an exclusive monopoly on a treatment for COVID-19.